Log In
Print
BCIQ
Print
Print this Print this
 

E7820

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionIntegrin alpha(2) expression inhibitor
Molecular Target Integrin alpha(2) (VLA-2) (CD49B)
Mechanism of ActionIntegrin inhibitor
Latest Stage of DevelopmentPhase II
IndicationColorectal cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today